CompletedNot applicableNCT04149951

Effect of VeSTAL Device in Type 2 Diabetes Mellitus

Studying NON RARE IN EUROPE: Metabolic syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Neurovalens Ltd.
Principal Investigator
Carel Le Roux, MD PhD
UCD
Intervention
Vestal Device(device)
Enrollment
50 enrolled
Eligibility
18-80 years · All sexes
Timeline
20202021

Study locations (1)

Collaborators

Compliance Solutions Ltd. · University College Dublin · Exploristics Ltd

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04149951 on ClinicalTrials.gov

Other trials for NON RARE IN EUROPE: Metabolic syndrome

Additional recruiting or active studies for the same condition.

See all trials for NON RARE IN EUROPE: Metabolic syndrome

← Back to all trials